Search research articles
Contact Us
Filters
Showing results (381-390 of 432) with videos related to
Page
of 44
Sort By:
Nutrients
|
April 12, 2022
Daily Exposure to a Cranberry Polyphenol Oral Rinse Alters the Oral Microbiome but Not Taste Perception in PROP Taster Status Classified Individuals
Neeta Y Yousaf, Guojun Wu, Melania Melis, et al.
Cephalalgia : an International Journal of Headache
|
March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Stewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache
|
August 9, 2018
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Dawn C Buse, Richard B Lipton, Yngve Hallström, et al.
Neurology
|
June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
NPJ Digital Medicine
|
May 13, 2026
Integrated analysis of two randomized controlled trials of a digital therapeutic for episodic migraine prevention
Shaheen E Lakhan, Mariya Petrova, Cassandra Snipes, et al.
Annals of Surgery
|
September 1, 1982
The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy
S A Rosenberg, J Tepper, E Glatstein, et al.
Headache
|
March 4, 2025
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study
David W Dodick, Stewart J Tepper, Jessica Ailani, et al.
Nature Communications
|
July 11, 2014
Lasing from active optomechanical resonators
T Czerniuk, C Brüggemann, J Tepper, et al.
The Journal of Headache and Pain
|
May 16, 2023
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
Stewart J Tepper, Jessica Cirillo, Edward Kim, et al.
Headache
|
February 17, 2021
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Ariane K Kawata, Neel Shah, Jiat-Ling Poon, et al.
Page
of 44
Search research articles
Search
Showing results (381-390 of 432) with videos related to
Sort By:
Page
of 44
Nutrients
|
April 12, 2022
Daily Exposure to a Cranberry Polyphenol Oral Rinse Alters the Oral Microbiome but Not Taste Perception in PROP Taster Status Classified Individuals
Neeta Y Yousaf, Guojun Wu, Melania Melis, et al.
Cephalalgia : an International Journal of Headache
|
March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Stewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache
|
August 9, 2018
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Dawn C Buse, Richard B Lipton, Yngve Hallström, et al.
Neurology
|
June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
NPJ Digital Medicine
|
May 13, 2026
Integrated analysis of two randomized controlled trials of a digital therapeutic for episodic migraine prevention
Shaheen E Lakhan, Mariya Petrova, Cassandra Snipes, et al.
Annals of Surgery
|
September 1, 1982
The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy
S A Rosenberg, J Tepper, E Glatstein, et al.
Headache
|
March 4, 2025
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study
David W Dodick, Stewart J Tepper, Jessica Ailani, et al.
Nature Communications
|
July 11, 2014
Lasing from active optomechanical resonators
T Czerniuk, C Brüggemann, J Tepper, et al.
The Journal of Headache and Pain
|
May 16, 2023
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
Stewart J Tepper, Jessica Cirillo, Edward Kim, et al.
Headache
|
February 17, 2021
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Ariane K Kawata, Neel Shah, Jiat-Ling Poon, et al.
Page
of 44